Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00854906 · ClinicalTrials.gov registry record
Keratometric Tear Breakup Time and Fluorescein Tear Breakup Time
A clinical trial, sponsored by University of Arkansas.
- Completed
- Registry status
- 26
- Enrollment target
NCT00854906: Completed study, sponsored by University of Arkansas.
NCT00854906 is a clinical trial that has completed, run by University of Arkansas. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00854906 has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
The purpose of the research is to determine if putting fluorescein onto the eye (most common test done for dry eye syndrome) is an accurate way to measure dry eye symptoms. The investigators can avoid placing any foreign substance into the eye by using a manual keratometer. Therefore, the investigators want to compare the measurements of tear breakup time using fluorescein with using a novel method, a manual keratometer and then compare these measurements to a validated dry eye symptoms questionnaire. All qualifying patients who were scheduled in the Jones Eye Institute Clinics for a complete eye exam were offered information about the study and invited to participate. Participants were recruited from February 29, 2009 to April 14, 2009.Participants who did not meet the study protocol's inclusion and exclusion criteria were not included the study or study data analysis. All subjects eyes were measured for KTBUT and FTBUT.
Primary Outcome
This outcome measures the difference in tear break up time using a keratometer and fluorescein dye.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2009-02 |
| Est. Completion | 2009-06 |
What the finished NCT00854906 record still lists
NCT00854906 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00854906 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00854906 about?
NCT00854906 is a clinical study titled "Keratometric Tear Breakup Time and Fluorescein Tear Breakup Time". The purpose of the research is to determine if putting fluorescein onto the eye (most common test done for dry eye syndrome) is an accurate way to measure dry eye symptoms. The investigators can avoid placing any foreign substance into the eye by using a manual keratometer. Therefore, the investigat...
What is the current status of trial NCT00854906?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2009-02. Estimated completion is 2009-06.
Who is sponsoring clinical trial NCT00854906?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia